Driehaus Capital Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.6M | Buy |
2,101,781
+726,039
| +53% | +$9.52M | 0.22% | 145 |
|
|
2025
Q1 | $30.3M | Sell |
1,375,742
-118,049
| -8% | -$2.6M | 0.29% | 110 |
|
|
2024
Q4 | $39.9M | Sell |
1,493,791
-459,633
| -24% | -$12.3M | 0.33% | 101 |
|
|
2024
Q3 | $52.1M | Buy |
1,953,424
+693,032
| +55% | +$18.5M | 0.45% | 70 |
|
|
2024
Q2 | $22.7M | Sell |
1,260,392
-7,427
| -0.6% | -$134K | 0.22% | 128 |
|
|
2024
Q1 | $23.1M | Buy |
1,267,819
+872,750
| +221% | +$15.9M | 0.23% | 131 |
|
|
2023
Q4 | $4.32M | Buy |
+395,069
| New | +$4.32M | 0.05% | 274 |
|